用于放免治疗的核素研究进展

Advances in radionuclide for radioimmunotherapy

  • 摘要: 放射免疫治疗肿瘤具有独特优势,许多新的核素被用于制备肿瘤放免治疗药物。高能α、β粒子及抗肿瘤导向载体的应用促进了放免治疗药物的发展。本文介绍了用于放射免疫治疗的核素最新研究进展,归纳了用于放射免治疗的常用放射性核素,并比较了各自的优缺点,指出了放射性核素用于放射免疫治疗过程中存在的问题、可能的解决方法及今后的发展趋势。

     

    Abstract: Radioimmunotherapy (RIT)has superiority in treatment of cancer.the application of high energy α emmiter,β emmiter,electron capture radioisotopes and anti-cancer target carriers bring an innovation of RIT drugs.In this paper,it describes in detail the advances in radionuclide for RIT in the therapy of cancer and introduces the radionuclides,compares their advantages and disadvantages,and finally discusses the problems,potential solutions and directions in developing of radionuclide for RIT.

     

/

返回文章
返回